Cargando…

Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status

Detalles Bibliográficos
Autores principales: Yang, WH, Casale, T, Bateman, ED, Dahl, R, Pizzichini, E, Vandewalker, M, Virchow, JC, Engel, M, Moroni-Zentgraf, PM, Schmidt, H, Kerstjens, HAM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304131/
http://dx.doi.org/10.1186/1710-1492-10-S2-A52
_version_ 1782354038960947200
author Yang, WH
Casale, T
Bateman, ED
Dahl, R
Pizzichini, E
Vandewalker, M
Virchow, JC
Engel, M
Moroni-Zentgraf, PM
Schmidt, H
Kerstjens, HAM
author_facet Yang, WH
Casale, T
Bateman, ED
Dahl, R
Pizzichini, E
Vandewalker, M
Virchow, JC
Engel, M
Moroni-Zentgraf, PM
Schmidt, H
Kerstjens, HAM
author_sort Yang, WH
collection PubMed
description
format Online
Article
Text
id pubmed-4304131
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43041312015-02-12 Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status Yang, WH Casale, T Bateman, ED Dahl, R Pizzichini, E Vandewalker, M Virchow, JC Engel, M Moroni-Zentgraf, PM Schmidt, H Kerstjens, HAM Allergy Asthma Clin Immunol Meeting Abstract BioMed Central 2014-12-18 /pmc/articles/PMC4304131/ http://dx.doi.org/10.1186/1710-1492-10-S2-A52 Text en Copyright © 2014 Yang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Yang, WH
Casale, T
Bateman, ED
Dahl, R
Pizzichini, E
Vandewalker, M
Virchow, JC
Engel, M
Moroni-Zentgraf, PM
Schmidt, H
Kerstjens, HAM
Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
title Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
title_full Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
title_fullStr Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
title_full_unstemmed Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
title_short Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
title_sort tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of t(h)2 inflammatory status
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304131/
http://dx.doi.org/10.1186/1710-1492-10-S2-A52
work_keys_str_mv AT yangwh tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT casalet tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT batemaned tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT dahlr tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT pizzichinie tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT vandewalkerm tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT virchowjc tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT engelm tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT moronizentgrafpm tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT schmidth tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus
AT kerstjensham tiotropiumrespimataddontherapyreducesairflowobstructioninpatientswithsymptomaticmoderateasthmaindependentofth2inflammatorystatus